Celyad, the new face of Cardio3, is launching an IPO on NASDAQ
[UPDATE 19/06/2015]: Yesterday, Celyad launched its IPO on NASDAQ and the closing is expected to occur…
June 19, 2015 - 2 minutes
Cardiovascular disease
Poor topline results for NeuroVive’s CicloMulsion Phase III
Phase III is a critical step in a drug development process. NeuroVive Pharmaceutical has learned…
June 3, 2015 - 2 minutes
NewCo, the union of Sorin and Cyberonics
[UPDATE 27/05/2015]: Sorin' shareholders approved the merger with Cyberonics in an Extraordinary Meeting. Sorin and…
May 27, 2015 - 3 minutes
Heart Metabolics bargain with the FDA for a single Phase III
Heart Metabolics received an agreement letter from the FDA related to the company's proposed phase…
April 15, 2015 - 2 minutes
Cardio3 Biosciences Embedded BioLife Solutions for a Heart Regenerative Therapy
Cardio3 BioSciences is again on the front page of biotech news. After announcing the launching of…
April 11, 2015 - 2 minutes
A New Key Strategic Collaboration Between BMS and UniQure
Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at…
April 7, 2015 - 3 minutes
Interview with CELLPROTHERA, the regenerative medicine pioneer
CellProthera is a medical biotech company founded in 2008 in Mulhouse, France. The young innovative…
April 2, 2015 - 7 minutes
Neurostimulation, an Innovative Approach to Treat Heart Failure
The revolutionary Equilia system, meant to treat heart failure, has been successfully implanted for the…
February 12, 2015 - 2 minutes
A Hydrogel to treat Advanced Heart Failure in Europe
LoneStar Heart, Inc. announced that it received the CE Mark (European Conformity) for its Algisyl-LVR® hydrogel implant,a…
October 4, 2014 - 2 minutes
EMA give Orphan Drug Designation to the CER-001 of Cerenis
Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-beta HDL mimetic, for…
September 3, 2014 - 3 minutes
Why should you drink tea instead of coffee?
Drinking tea reduces non-cardiovascular mortality by 24%, reveals a study in 131 000 people presented…
August 31, 2014 - 4 minutes
